Abstract
An in-house library of 200 molecules from natural plant products was designed in order to evaluate their binding to Plasmodium ACP enoyl reductase (ENR), a promising biological target for antimalarial chemotherapeutics. The binding site of PfENR was explored computationally and the molecules were docked using AutoDock. Furthermore, the top-ranked scaffolds from docking studies were also compared with known PfENR inhibitors using 3D-QSAR. To this effect, a 3D-QSAR model was derived from a set of experimentally established PfENR inhibitors, using Comparative Molecular Force Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA). The best optimum CoMFA model exhibited a leave-one-out correlation coefficient (q2) and a noncross- validated correlation coefficient (r2) of 0.630 and 0.911, respectively. The result of this cumulative approach proposed five structurally distinct natural products as potent PfENR inhibitors. This study may lay a stepping stone towards Functional oriented synthesis (FOS) of novel PfENR inhibitors in future.
Keywords: Malaria, Plasmodium ACP enoylreductase (FabI), Molecular docking, CoMFA analysis, drug design.
Current Computer-Aided Drug Design
Title:Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors
Volume: 11 Issue: 3
Author(s): Preeti Wadhwa, Debasmita Saha and Anuj Sharma
Affiliation:
Keywords: Malaria, Plasmodium ACP enoylreductase (FabI), Molecular docking, CoMFA analysis, drug design.
Abstract: An in-house library of 200 molecules from natural plant products was designed in order to evaluate their binding to Plasmodium ACP enoyl reductase (ENR), a promising biological target for antimalarial chemotherapeutics. The binding site of PfENR was explored computationally and the molecules were docked using AutoDock. Furthermore, the top-ranked scaffolds from docking studies were also compared with known PfENR inhibitors using 3D-QSAR. To this effect, a 3D-QSAR model was derived from a set of experimentally established PfENR inhibitors, using Comparative Molecular Force Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA). The best optimum CoMFA model exhibited a leave-one-out correlation coefficient (q2) and a noncross- validated correlation coefficient (r2) of 0.630 and 0.911, respectively. The result of this cumulative approach proposed five structurally distinct natural products as potent PfENR inhibitors. This study may lay a stepping stone towards Functional oriented synthesis (FOS) of novel PfENR inhibitors in future.
Export Options
About this article
Cite this article as:
Wadhwa Preeti, Saha Debasmita and Sharma Anuj, Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors, Current Computer-Aided Drug Design 2015; 11 (3) . https://dx.doi.org/10.2174/1573409911666151030102113
DOI https://dx.doi.org/10.2174/1573409911666151030102113 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Macrocyclic Proteasome Inhibitors
Current Medicinal Chemistry Synthetic Peptides for the Immunodiagnosis of Human Diseases
Current Medicinal Chemistry Evaluation of the Agreement Between the Tissue Sample and Bronchoalveolar Lavage (BAL) Fluid in the Diagnosis of Tuberculosis in Patients with Anthracosis
Current Respiratory Medicine Reviews Resolving Differences in Substrate Specificities between Human and Parasite Phosphoribosyltransferases via Analysis of Functional Groups of Substrates and Receptors
Current Pharmaceutical Design Recent Innovations of Organo-fluorine Synthesis and Pharmacokinetics
Current Organic Chemistry Immunotoxicity and Immunogenicity of Biopharmaceuticals: Design Concepts and Safety Assessment
Current Drug Safety Despite an Extensive Sequence Analysis Identification of Functional Candidates Amongst Hypothetical Proteins of Neisseria gonorrhoeae
Letters in Drug Design & Discovery Migration and Function of Th17 Cells
Inflammation & Allergy - Drug Targets (Discontinued) Recent Patents for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Roles of L5-7 Loop in the Structure and Chaperone Function of SsHSP14.1
Protein & Peptide Letters Randomized Clinical Trials in Children - Ethical and Methodological Issues
Current Pharmaceutical Design Recent Advances and Future Perspectives of Triazole Analogs as Promising Antiviral Agents
Mini-Reviews in Medicinal Chemistry MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) Dysregulation of RNA Mediated Gene Expression in Motor Neuron Diseases
CNS & Neurological Disorders - Drug Targets Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs
Current Pharmaceutical Design Effects of Chrisotherapeutic Gold Compounds on Prostaglandin E2 Production
Current Drug Targets - Inflammation & Allergy Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy
Recent Patents on Anti-Infective Drug Discovery New Insights in Design and Development of Antitubercular Drugs
Current Bioactive Compounds Dibenzofurans from Lichens – A Pharmacological Overview
Current Topics in Medicinal Chemistry Artemisia Species as Potential Weapon Against Agents and Agricultural Pests
Current Biotechnology